Skip to content
Taxonomy
CMTA Seed Money Draws NIH Support For Type 2 Gene Editing
CMTA Seed Money Draws NIH Support For Type 2 Gene Read More
CMTA-STAR Awards $354,826 for CMT Clinical Trial
CMTA-STAR Awards $354,826 for CMT Clinical Trial (Glenolden, PA, December Read More
CMTA-STAR Awards Researcher $98,985 For CMT1A Project
CMTA-STAR Awards Researcher $98,985 For CMT1A Project Using Dental Pulp Read More
CMTA and Taysha Gene Therapies Announce Collaboration for CMT4A
CMTA and Taysha Gene Therapies Announce Collaboration for CMT4A (Glenolden, Read More
CMTA and Applied Therapeutics Announce Collaboration for CMT-SORD
CMTA and Applied Therapeutics Announce Collaboration for CMT-SORD (Glenolden, PA, Read More
Taysha Gene Therapies & CMTA Collaborate to Increase Genetic Testing Access for Giant Axonal Neuropathy (GAN)
Taysha Gene Therapies Announces Sponsored Genetic Testing for Giant Axonal Read More
CMTA and ToolGen Announce CMT1A Collaboration
CMTA and ToolGen Announce Collaboration to Develop Potential Treatment for Read More
CMTA and Addex Announce CMT1A Collaboration
CMTA and Addex Therapeutics Enter Collaboration to Advance GABA B Read More
CMTA-STAR Awards $1.1 Million for CMT1X, CMT2A Clinical Trials
CMTA-STAR announced $1.1 million in grants March 23 aimed at helping top CMT scientists prepare for clinical trials for CMT1X and CMT2ACMTA and Pharnext Enter Biomarker Research Collaboration
Collaboration focused on identifying and characterizing key biomarkers
in Charcot-Marie-Tooth disease Type 1A
